Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma-Takeaways From Modern Randomized Trials. Review uri icon

Overview

abstract

  • Sublobar resection for early-stage non-small cell lung cancer has been an emerging topic of great interest to thoracic surgeons. However, data regarding the efficacy and safety of sublobar resection vs lobectomy was lacking until now. Recently, 3 published randomized controlled trials (Cancer and Leukemia Group B [CALGB]140503/Alliance, Japan Clinical Oncology Group [JCOG]0802 and Das Deutsche Register Klinischer Studien [DRKS]00004897) confirmed the noninferiority of sublobar resection for early-stage non-small cell lung cancer in carefully selected populations. This review aims to summarize and compare these 3 landmark trials and inform surgeons of new best practices.

publication date

  • January 5, 2024

Research

keywords

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Neoplasm Staging
  • Pneumonectomy
  • Randomized Controlled Trials as Topic

Identity

Scopus Document Identifier

  • 85183553391

Digital Object Identifier (DOI)

  • 10.1016/j.athoracsur.2023.12.008

PubMed ID

  • 38184163

Additional Document Info

volume

  • 117

issue

  • 5